Agmatine Sulfate

A metabolite of L-arginine produced by decarboxylation. Agmatine is an endogenous neuromodulator that acts on multiple receptor systems — it blocks NMDA receptors, activates imidazoline receptors, inhibits nitric oxide synthase, and modulates opioid signaling. This makes it useful for neuropathic pain, mood, stress resilience, and as a complement to other nootropics. Also enhances insulin sensitivity and nitric oxide production.

Dosage

Standard: 500-2000 mg daily in 1-3 doses. For mood: 1000-2000 mg. For pain: 1000-2500 mg. Take on empty stomach. Agmatine sulfate is the most common supplement form. May enhance the effects of some nootropics and medications — research interactions.

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

2-3 hours

Administration

Oral (powder, capsules). Take on empty stomach for best absorption.

Shop Agmatine Sulfate

99%+ purity · third-party lab tested

Browse →

Mechanism of Action

Agmatine is a polyamine neuromodulator with multiple targets: (1) NMDA receptor antagonist at the polyamine binding site (GluN1/GluN2B) — reduces excitotoxicity, pain signaling, and blocks the receptor's open channel. (2) Imidazoline I1 and I2 receptor agonist — I1 in the rostral ventrolateral medulla reduces sympathetic tone; I2 modulates monoamine oxidase and provides anxiolytic/antidepressant effects. (3) Selective nNOS (neuronal nitric oxide synthase) inhibitor — reduces peroxynitrite formation and oxidative stress while preserving eNOS (endothelial) function for vascular health. (4) Alpha-2 adrenergic receptor agonist — reduces norepinephrine release from locus coeruleus, promoting calm. (5) Modulates opioid receptors — enhances mu-opioid analgesia, potentiates delta-opioid, and may reduce tolerance via nitric oxide and NMDA mechanisms.

Regulatory Status

Dietary supplement. Available OTC worldwide. Not FDA-approved for any medical condition.

Risks & Safety

Common

Mild gastrointestinal discomfort, diarrhea at high doses.

Serious

May potentiate opioid medications (increased sedation risk). May lower blood pressure.

Rare

Headache, nausea.

Compare Agmatine Sulfate With

Research Papers

10
Effect of Agmatine Sulfate on Modulation of Matrix Metalloproteinases via PI3K/Akt-1 in HT1080 Cells.

Published: October 31, 2017

AI Summary

The purpose of this study was to investigate the mechanism by which agmatine sulfate induces an anti-metastatic effect in human HT1080 fibrosarcoma cells, by affecting matrix metalloproteinases (MMPs).

Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate.

Published: September 2, 2019

AI Summary

However, a significant translational step would be the use of oral agmatine treatment at therapeutic doses and better understanding of L-arginine metabolic profiles in the CNS post-treatment. This study provides fundamental pre-clinical evidence that daily oral delivery of agmatine sulfate to both WT and Tg mice is safe and well tolerated.

Evidence for Dietary Agmatine Sulfate Effectiveness in Neuropathies Associated with Painful Small Fiber Neuropathy. A Pilot Open-Label Consecutive Case Series Study.

Published: February 22, 2020

AI Summary

Based on this evidence, we conducted an open-label consecutive case series study to evaluate the effectiveness of agmatine in neuropathies associated with painful SFN (Study Registry: ClinicalTrials.gov, System Identifier: NCT01524666).

Evidence for safety of the dietary ingredient agmatine sulfate as assessed by mutagenicity and genotoxicity studies.

Published: December 29, 2024

AI Summary

Clinical trials have demonstrated the safety of oral agmatine sulfate and have led to its development as an effective dietary ingredient for promoting resilient nerve functions. And it lacked genotoxic effects as evidenced by the lack of increased frequency of micronucleated polychromatic immature erythrocytes following oral administration in th...

Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats.

Published: December 15, 2013

AI Summary

Agmatine-treated rats showed slight, but significant reductions in body weight and blood pressure, and reduced water consumption during treatment, which recovered completely within 20 days after treatment cessation.

Agmatine Administration Effects on Equine Gastric Ulceration and Lameness.

Published: December 7, 2022

AI Summary

Agmatine plasma levels peaked between 30 and 60 min and were largely undetectable by 24 h after oral administration. In contrast, plasma citric acid levels increased throughout agmatine administration, representing a shift in the metabolomic profile.

Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial.

Published: March 7, 2010

AI Summary

This study was designed to ascertain safety and efficacy of dietary agmatine sulfate in herniated lumbar disc-associated radiculopathy. Expressed as percent of baseline values, significantly enhanced improvement in average pain measures and in quality of life scores occurred after treatment in the agmatine group (26.7% and 70.

Agmatine for Pain Management in Dogs With Coxofemoral Joint Osteoarthritis: A Pilot Study.

Published: December 11, 2018

AI Summary

Significant results included improved GRFs in dogs with mild CFJ OA (N = 3) following agmatine administration compared to carprofen or placebo and a trend for improved GRFs in dogs with moderate CFJ OA (N = 2) following carprofen vs. agmatine or placebo. Neither agmatine nor carprofen improved GRFs in dogs with severe CFJ OA (N = 4).

Analysis of Regulatory Mechanism of AcrB and CpxR on Colistin Susceptibility Based on Transcriptome and Metabolome of Salmonella Typhimurium.

Published: August 16, 2023

AI Summary

Collectively, these findings have revealed several previously unknown mechanisms contributing to increased colistin susceptibility and identified potential targets and adjuvants for potentiating colistin treatment of Salmonella infections.

Effect of agmatine on experimental vascular endothelial dysfunction.

Published: May 29, 2016

AI Summary

Serum lipid profile, serum thiobarbituric acid reactive substances, reduced glutathione, superoxide dismutase generation, serum nitrite/nitrate, serum vascular cellular adhesion molecule-1 (VCAM-1), and aortic nuclear factor κB (NF-κB) levels were analyzed.

Frequently Asked Questions

What is Agmatine Sulfate used for?

A metabolite of L-arginine produced by decarboxylation. Agmatine is an endogenous neuromodulator that acts on multiple receptor systems — it blocks NMDA receptors, activates imidazoline receptors, inhibits nitric oxide synthase, and modulates opioid signaling. This makes it useful for neuropathic pain, mood, stress resilience, and as a complement to other nootropics. Also enhances insulin sensitivity and nitric oxide production.

What are the side effects of Agmatine Sulfate?

Common: Mild gastrointestinal discomfort, diarrhea at high doses. Serious: May potentiate opioid medications (increased sedation risk). May lower blood pressure. Rare: Headache, nausea.

How is Agmatine Sulfate administered?

Agmatine Sulfate is administered via oral (powder, capsules). take on empty stomach for best absorption..

What is the half-life of Agmatine Sulfate?

The half-life of Agmatine Sulfate is 2-3 hours.

Related Nootropics

5-HTP

5-Hydroxytryptophan is the immediate precursor to serotonin, derived from the seeds of Griffonia simplicifolia. By providing the rate-limiting intermediate in serotonin synthesis, 5-HTP effectively raises brain serotonin levels. Used for mood support, anxiety, sleep, and appetite control. More effective than L-Tryptophan because it bypasses the rate-limiting enzyme step.

Mood & AnxietySleep & Recovery

ALCAR

Acetyl-L-Carnitine is an acetylated form of L-Carnitine that crosses the blood-brain barrier more effectively than regular L-Carnitine. In the brain, it donates its acetyl group for acetylcholine synthesis and supports mitochondrial fatty acid oxidation for energy. Used clinically for age-related cognitive decline, depression, and diabetic neuropathy.

MitochondrialMood & AnxietyNeuroprotection

Aniracetam

A fat-soluble racetam roughly 5-10x more potent than Piracetam by weight. Known for its anxiolytic (anti-anxiety) properties alongside cognitive enhancement — a combination that makes it popular for social situations and creative work. It modulates both glutamate and dopamine/serotonin systems, giving it a unique mood-lifting quality that other racetams lack.

RacetamsMood & Anxiety

Ashwagandha

An Ayurvedic adaptogen used for over 3,000 years that has become one of the most popular and well-studied supplements for stress, anxiety, and cognitive function. Ashwagandha (Withania somnifera) significantly reduces cortisol levels, improves stress resilience, and enhances memory and reaction time. KSM-66 and Sensoril are the two most studied standardized extracts.

AdaptogensMood & Anxiety

B-Complex

The B vitamins (B1, B2, B3, B5, B6, B9, B12) are essential coenzymes in brain energy metabolism, neurotransmitter synthesis, and methylation reactions. Deficiency in any B vitamin impairs cognitive function. B12 and folate deficiency specifically cause irreversible neurological damage if untreated. A high-quality B-complex is foundational for any nootropic regimen, particularly for vegetarians, older adults, and those under chronic stress.

NeuroprotectionMood & Anxiety

Bacopa Monnieri

An Ayurvedic herb used for thousands of years as a memory enhancer. Modern research confirms it — Bacopa reliably improves memory formation, recall speed, and information retention. The catch is that benefits require 8-12 weeks of daily use to manifest; it is not an acute cognitive enhancer. The bacosides (active compounds) are also mildly sedating, making evening dosing common.

AdaptogensNeuroprotection